Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression - Editorial comment

Authors
Crawford, ED
Citation
Ed. Crawford, Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression - Editorial comment, UROLOGY, 58(2), 2001, pp. 150-151
Citations number
1
Categorie Soggetti
Urology & Nephrology
Journal title
UROLOGY
ISSN journal
00904295 → ACNP
Volume
58
Issue
2
Year of publication
2001
Pages
150 - 151
Database
ISI
SICI code
0090-4295(200108)58:2<150:B(1MAI>2.0.ZU;2-N